United Therapeutics Co. (NASDAQ:UTHR) CEO Martine A. Rothblatt Sells 3,600 Shares
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) CEO Martine A. Rothblatt sold 3,600 shares of the company’s stock in a transaction that occurred on Friday, April 26th. The stock was sold at an average price of $235.20, for a total value of $846,720.00. Following the completion of the sale, the chief executive officer now […]
More Stories
NBC Securities Inc. Sells 64 Shares of Align Technology, Inc. (NASDAQ:ALGN)
NBC Securities Inc. lessened its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 15.9% in the...
QRG Capital Management Inc. Buys 20,205 Shares of JPMorgan Chase & Co. (NYSE:JPM)
QRG Capital Management Inc. increased its stake in JPMorgan Chase & Co. (NYSE:JPM) by 5.1% during the fourth quarter, according...
USA Financial Formulas Purchases 2,694 Shares of JPMorgan Chase & Co. (NYSE:JPM)
USA Financial Formulas grew its position in JPMorgan Chase & Co. (NYSE:JPM) by 8,163.6% in the fourth quarter, according to...
Schulhoff & Co. Inc. Reduces Holdings in JPMorgan Chase & Co. (NYSE:JPM)
Schulhoff & Co. Inc. lessened its stake in shares of JPMorgan Chase & Co. (NYSE:JPM – Free Report) by 0.1%...
JPMorgan Chase & Co. (NYSE:JPM) Shares Sold by One Capital Management LLC
One Capital Management LLC lessened its holdings in JPMorgan Chase & Co. (NYSE:JPM – Free Report) by 1.3% during the...
Private Portfolio Partners LLC Decreases Stock Position in JPMorgan Chase & Co. (NYSE:JPM)
Private Portfolio Partners LLC trimmed its position in shares of JPMorgan Chase & Co. (NYSE:JPM) by 0.9% in the 4th...